BioNanomatrix has appointed biophysicist Paul Selvin to its scientific advisory board, the firm said last week. Selvin is a professor of physics and biophysics at the University of Illinois at Urbana-Champaign.
The California Healthcare Institute said last week that it has elected Daniel O’Day and Michael Onuscheck to its board of directors.
O’Day is currently president and CEO at Roche Molecular Diagnostics in Pleasanton, Calif. Onuscheck is president of the neuromodulation division at Boston Scientific.
CHI is a non-profit public-policy research organization representing California’s academic institutions, and biotechnology, medical device, diagnostics, and pharmaceutical firms.
Christophe Lambert, CEO of software firm Golden Helix, will co-chair the Copy Number Variation Data Analysis Team within the Microarray Quality Control project’s Genome-Wide Association Working Group, Golden Helix said last week.
Lambert will join co-chair Francesca Demichelis of the Institute for Computational Biomedicine at Weill Cornell Medical College.
The CNV Data Analysis Team now has over 50 members and aims to identify the sources of variation in results of analysis of copy number data on whole-genome microarrays.